← All companies

EQ

Equillium, Inc.

EQ Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.20

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$139M

Revenue (TTM)

$41.1M

Net income (TTM)

-$19.1M

EPS (TTM)

$-0.21

P/E ratio

—

Dividend yield

—

Free cash flow

-$22.8M

Cash

$61.3M

Total assets

$63.1M

Gross margin

—

52-week range

$0.46 – $3.54

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results May 29, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release) Mar 25, 2026 8-K Entered a material agreement; Unregistered sale of equity Mar 13, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K/A Changed accountants Oct 24, 2025 8-K Changed accountants; Director or officer change; Other events Oct 6, 2025 8-K Other events Sep 19, 2025 8-K Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 11, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure; Other events Aug 4, 2025 8-K Delisting notice or listing-rule failure Jun 13, 2025 8-K Director or officer change; Shareholder vote results May 22, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) Apr 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Other events Feb 6, 2025 8-K Delisting notice or listing-rule failure Dec 13, 2024 8-K Director or officer change Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Other events Oct 31, 2024 8-K Other events Oct 31, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Delisting notice or listing-rule failure Jul 23, 2024 8-K Results of operations (earnings release) Jul 18, 2024 8-K Other events Jun 4, 2024 8-K Shareholder vote results May 23, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Other events Apr 1, 2024 10-K Fiscal year ended 2023-12-31 Mar 25, 2024 8-K Results of operations (earnings release) Mar 25, 2024 8-K Director or officer change; Other events Mar 8, 2024